Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
The Cancer Center of Hawaii-Pali Momi
mi
from
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Aurora Cancer Care-Southern Lakes VLCC
mi
from
Burlington, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Essentia Health Saint Mary's - Detroit Lakes Clinic
mi
from
Detroit Lakes, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Walter Knox Memorial Hospital
mi
from
Emmett, ID
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Hawaii Cancer Care Inc-Liliha
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
OptumCare Cancer Care at Fort Apache
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Marshfield Medical Center-Marshfield
mi
from
Marshfield, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
The West Clinic - Mid-Town
mi
from
Memphis, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Lakeland Hospital Niles
mi
from
Niles, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Reid Health
mi
from
Richmond, IN
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Epic Care Cyberknife Center
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Ipilimumab With or Without Nivolumab in Treating Patients With Melanoma That Is Stage IV or Stage III and Cannot Be Removed by Surgery
Status: Enrolling, Phase II
Updated: 12/31/1969
Fairview Lakes Medical Center
mi
from
Wyoming, MN
Click here to add this to my saved trials
Gastroenterology, Oncology Clinical Trial
Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas
Status: Enrolling, Phase II
Updated: 12/31/1969
Siteman Cancer Center at West County Hospital
mi
from
Creve Coeur, MO
Click here to add this to my saved trials
Oncology Clinical Trial
A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)
Status: Enrolling, Phase I
Updated: 12/31/1969
UZ Antwerpen
mi
from
Edegem,
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Anchorage, AK
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Billings, MT
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Denver, CO
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Gainesville, FL
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Newark, DE
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, MN
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sioux City, IA
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sioux Falls, SD
Click here to add this to my saved trials
Cholangiocarcinoma Clinical Trial
Efficacy and Safety of Pemigatinib in Subjects With Advanced/Metastatic or Surgically Unresectable Cholangiocarcinoma Who Failed Previous Therapy - (FIGHT-202)
Status: Enrolling, Phase II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Waco, TX
Click here to add this to my saved trials
Oncology Clinical Trial
Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor
Status: Enrolling, Phase II
Updated: 12/31/1969
HealthPartners Institute
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Advanced Radiation Centers of New York (Integrated Medical Professionals)
mi
from
Plainview, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Randomized Controlled Trial of ProstAtak® Immunotherapy During Active Surveillance for Prostate Cancer (ULYSSES)
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Woodland Center
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome
Status: Enrolling, Phase
Updated: 12/31/1969
University of Pittsburg
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology Clinical Trial
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
Status: Enrolling, Phase
Updated: 12/31/1969
Hospital for Sick Children
mi
from
Toronto,
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Austin, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Centennial, CO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Clearwater, FL
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
East Windsor, NJ
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Encinitas, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Fridley, MN
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Richmond, VA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Saint Joseph, MO
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
San Diego, CA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Atopic Dermatitis Clinical Trial
Open-label Study of Dupilumab (REGN668/SAR231893) in Patients With Atopic Dermatitis
Status: Enrolling, Phase III
Updated: 2/7/2017
Clinical Research Facility
mi
from
Waco, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
A Six Week Efficacy, Safety and Tolerability Study of V565 in Crohn's Disease
Status: Enrolling, Phase II
Updated: 12/31/1969
West Central Gastroenterology
mi
from
Clearwater, FL
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: Enrolling, Phase III
Updated: 12/31/1969
Princess Margaret Hospital for Children
mi
from
Perth,
Click here to add this to my saved trials
Clinical Trial
Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations
Status: Enrolling, Phase II
Updated: 12/31/1969
Nebraska Medicine-Bellevue
mi
from
Bellevue, NE
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
St. John Clinic
mi
from
Bartlesville, OK
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Ascension St. John Hospital and Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
PinnacleHealth Harrisburg Hospital
mi
from
Harrisburg, PA
Click here to add this to my saved trials
Peripheral Arterial Disease Clinical Trial
Shockwave Medical Peripheral Lithoplasty System Study for PAD (Disrupt PAD III)
Status: Enrolling
Updated: 12/31/1969
Pinnacle Health Cardiovascular Institute
mi
from
Wormleysburg, PA
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
University of Colorado Denver Primary Center
mi
from
Denver, CO
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Thomas Jefferson University Hospital Headache Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Mayo Clinic in Arizona Headache Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Migraine Clinical Trial
The MOTS (Medication Overuse Treatment Strategy) Trial
Status: Enrolling
Updated: 12/31/1969
Study MEtrix, LLC
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Pneumonia Clinical Trial
Trial to Evaluate Beta-Lactam Antimicrobial Therapy of Community Acquired Pneumonia in Children
Status: Enrolling, Phase IV
Updated: 12/31/1969
Children's Hospital of Pittsburgh of UPMC - General Academic Pediatric
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
WR-ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut GI, PC - Research Division
mi
from
Farmington, CT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Research Institute
mi
from
Lakewood Ranch, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Synexus Clinical Research US, Inc./Wasatch Peak Family Practice
mi
from
Layton, UT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Spring Gastroenterology
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Medical Clinic
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Malignancies Clinical Trial
Study of REGN3767 (Anti-LAG-3) With or Without REGN2810 (Anti-PD1) in Advanced Cancers
Status: Enrolling, Phase I
Updated: 12/31/1969
Seoul National University Hospital
mi
from
Seoul,
Click here to add this to my saved trials
Oncology Clinical Trial
Study of MK-1454 Alone or in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001)
Status: Enrolling, Phase I
Updated: 12/31/1969
Mount Sinai Hosp
mi
from
New York, NY
Click here to add this to my saved trials
Non Small Cell Lung Cancer Metastatic Clinical Trial
Hypofractionated Radiation Therapy to Improve Immunotherapy Response in Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 12/31/1969
WVU Cancer Institute - Mary Babb Randolph Cancer Center
mi
from
Morgantown, WV
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Augusta, GA
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
mi
from
Buenos Aires,
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
New Bern, NC
Click here to add this to my saved trials
Chronic Kidney Disease Clinical Trial
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Lonetree, CO
Click here to add this to my saved trials
Non-Alcoholic Steatohepatitis (NASH) Clinical Trial
Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)
Status: Enrolling, Phase II
Updated: 12/31/1969
Novartis Investigative Site
mi
from
Morehead City, NC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Identifying, Understanding, and Overcoming Barriers to the Use of Clinical Practice Guidelines in Pediatric Oncology
Status: Enrolling, Phase
Updated: 12/31/1969
Sanford Broadway Medical Center
mi
from
Fargo, ND
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mount Sinai School of Medicine - Corinne Goldsmith Dickinson Center for Multiple Sclerosis
mi
from
New York, NY
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
Thomas Jefferson University Hospital - Dpt Neurology MS Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Multiple Sclerosis Clinical Trial
Clinical Study to Compare the Efficacy and Safety of Ponesimod to Placebo in Subjects With Active Relapsing Multiple Sclerosis Who Are Treated With Dimethyl Fumarate (Tecfidera®)
Status: Enrolling, Phase III
Updated: 12/31/1969
Care Access Research - Santa Clarita
mi
from
Santa Clarita, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Pali Momi Medical Center
mi
from
'Aiea, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Nivolumab in Treating Patients With Localized Kidney Cancer Undergoing Nephrectomy
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Joseph Mercy Brighton
mi
from
Brighton, MI
Click here to add this to my saved trials
Connective Tissue Disease-Associated Pulmonary Arterial Hypertension Clinical Trial
Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
Status: Enrolling, Phase III
Updated: 12/31/1969
NYU Langone Health
mi
from
New York, NY
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
WR-ClinSearch, LLC
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Connecticut GI, PC - Research Division
mi
from
Farmington, CT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Research Institute
mi
from
Lakewood Ranch, FL
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Synexus Clinical Research US, Inc./Wasatch Peak Family Practice
mi
from
Layton, UT
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Spring Gastroenterology
mi
from
The Woodlands, TX
Click here to add this to my saved trials
Crohn's Disease Clinical Trial
Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease
Status: Enrolling, Phase III
Updated: 12/31/1969
Florida Medical Clinic
mi
from
Zephyrhills, FL
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigator Site - Boston
mi
from
Boston, MA
Click here to add this to my saved trials
Oncology Clinical Trial
A Study of Etirinotecan Pegol (NKTR-102) Versus Treatment of Physician's Choice (TPC) in Patients With Metastatic Breast Cancer Who Have Stable Brain Metastases and Have Been Previously Treated With an Anthracycline, a Taxane, and Capecitabine
Status: Enrolling, Phase III
Updated: 12/31/1969
Investigator Site - Nashville
mi
from
Nashville, TN
Click here to add this to my saved trials
Peripheral Artery Disease Clinical Trial
Safety/Feasibility of Vonapanitase Following Angioplasty for Patients With Peripheral Artery Disease (PAD) Below the Knee (BTK)
Status: Enrolling, Phase I
Updated: 12/31/1969
UF Health at the University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Clinical Trial
Resetting the Default: Improving Provider-patient Communication to Reduce Antibiotic Misuse
Status: Enrolling
Updated: 12/31/1969
Children's Mercy Pediatric Care Clinic
mi
from
Kansas City, MO
Click here to add this to my saved trials